NCT02527486 Seoul National University Airway Registry
| NCT ID | NCT02527486 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Chronic Obstructive Pulmonary Disease (COPD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2011-09 |
| Primary Completion | 2021-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2011-09 with a primary completion date of 2021-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a multicenter, prospective observational cohort study, in which patients with chronic airway diseases including chronic obstructive pulmonary disease(COPD), asthma, asthma-COPD overlap syndrome (ACOS) will be recruited.
Eligibility Criteria
COPD Inclusion Criteria: * Postbronchodilator FEV1/FVC \< 0.7 AND chronic respiratory symptom Exclusion Criteria: \- Asthma Inclusion Criteria: * Never smoker or \<5PY of smoking history AND Recurrent episodes of asthma symptoms (wheezing, dyspnea, chest tightness, cough) AND (either Positive BDR OR positive metacholine/mannitol/exercise provocation test) Exclusion Criteria: \- ACOS Inclusion Criteria: * COPD AND Asthma (regardless of smoking status) Exclusion Criteria: \-
Contact & Investigator
Chul-Gyu Yoo, M.D.
STUDY CHAIR
Seoul National University Hospital
Frequently Asked Questions
Who can join the NCT02527486 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 90 Years, studying Chronic Obstructive Pulmonary Disease (COPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02527486 currently recruiting?
Yes, NCT02527486 is actively recruiting participants. Contact the research team at kauri670@gmail.com for enrollment information.
Where is the NCT02527486 trial being conducted?
This trial is being conducted at Seongnam-si, South Korea, Seoul, South Korea, Seoul, South Korea.
Who is sponsoring the NCT02527486 clinical trial?
NCT02527486 is sponsored by Seoul National University Hospital. The principal investigator is Chul-Gyu Yoo, M.D. at Seoul National University Hospital. The trial plans to enroll 800 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.